Clinical TrialsSearch results
Number of results: 480
Recruiting
- An Investigator-initiated Clinical Trial, First in Human study, wi th a natural-type micro RNA MIRX002, for patients with malignant pleural mesothelioma (MIRX002-01 repeated dose study)
- Malignant pleural mesothelioma
- Morihito Okada
- 2022-05-11
Recruiting
- An investigational study of chemoradiosensitivity prediction with genetic profiling of esophageal biopsy for squamous cell carcinoma of the esophagus
- Esophageal cancer
- University of Toyama
- 2007-02-01
Recruiting
- A study to determine the optimal dose of folic acid supplementation in patients with rheumatic diseases on methotrexate treatment
- Patients on methotrexate therapy regularly take folic acid supplementation to prevent its toxicity.
- Shintaro Hirata
- 2023-12-26
Recruiting
- A study on the efficacy and safety of ED1000 in post-prostatectomy patients
- Prostate cancer
- Hinata Nobuyuki
- 2023-11-09
Recruiting
- A study of the efficacy of preoperative marking for liver tumors
- Liver tumor
- Ohdan Hideki
- 2023-01-25
Recruiting
- A Study Evaluating the Efficacy and Safety of Giredestrant Plus Everolimus Compared With The Physician's Choice of Endcrine Therapy Plus Everolimus in Participants With Estrogen Receptor-Positive, HER2-Negative, Locally Advanced or Metastatic Breast Cancer (evERA Breast Cancer)
- Estrogen Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer
- Patricia Cortazar, M.D.
- 2023-02-28
Recruiting
- A Randomized, Double-blind, Parallel Group, Multi-center, Phase III Study to Assess the Efficacy of Budesonide, Glycopyrronium, and Formoterol Fumarate Metered Dose Inhaler Relative to Glycopyrronium and Formoterol Fumarate MDI on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease (THARROS)
- COPD
- Ageishi Yuji
- 2024-03-27
Recruiting
- A Phase III, Randomized, Open-Label, Multicenter, Global Study of Volrustomig (MEDI5752) in Combination With Carboplatin Plus Pemetrexed Versus Platinum Plus Pemetrexed or Nivolumab Plus Ipilimumab in Participants With Unresectable Pleural Mesothelioma.
- Unresectable Pleural Mesothelioma
- Hibi Kazushige
- 2023-11-11
Recruiting
- A Phase II study of the Perflubutane for predicting TILs in EBC (AppTIL study)
- Early Breast Cancer (cStage I-IIIA)
- Shigematsu Hideo
- 2023-01-07
Recruiting
- A phase II study of Pedmark (sodium thiosulfate anhydrate) to reduce ototoxicity induced by cisplatin for common malignancies in childhood and AYA (adolescent and young adult) patients
- Ototoxicity induced by cisplatin for common malignancies
- Hiyama Eiso
- 2022-05-19